Title:
TNF-α-BINDING APTAMER, AND THERAPEUTIC USE FOR SAME
Document Type and Number:
WIPO Patent Application WO/2018/079864
Kind Code:
A1
Abstract:
Disclosed are a TNF-α-binding RNA aptamer which is disclosed by SEQ ID NO: 1 or SEQ ID NO: 2, and a therapeutic use for same.tnf-α-binding aptamer, and therapeutic use for same
More Like This:
Inventors:
KIM SUNG CHUN (KR)
Application Number:
PCT/KR2016/011981
Publication Date:
May 03, 2018
Filing Date:
October 24, 2016
Export Citation:
Assignee:
KIM SUNG CHUN (KR)
International Classes:
C12N15/115; A61K31/7105
Domestic Patent References:
| WO2013185241A1 | 2013-12-19 | |||
| WO1991019813A1 | 1991-12-26 | |||
| WO2011130195A1 | 2011-10-20 |
Foreign References:
| KR101090177B1 | 2011-12-06 | |||
| JP2011155913A | 2011-08-18 | |||
| KR101261589B1 | 2013-05-06 | |||
| KR20150140669A | 2015-12-16 | |||
| US5475096A | 1995-12-12 | |||
| US5270163A | 1993-12-14 | |||
| US5660985A | 1997-08-26 | |||
| US5756703A | ||||
| US5580737A | 1996-12-03 | |||
| US5719273A | 1998-02-17 | |||
| US20040180360A1 | 2004-09-16 | |||
| US5262564A | 1993-11-16 |
Other References:
ANNU. REV. IMMUNOL., vol. 10, 1992, pages 411 - 452
ANNU. REV. MED., vol. 45, 1994, pages 491 - 503
INT IMMUNOPHARMACOL., vol. 8, no. 5, 2008, pages 679 - 87
BIOCONJUG. CHEM., vol. 24, no. 6, 2013, pages 915 - 25
GENE THER., vol. 14, no. 4, 2007, pages 283 - 291
SCIENCE, vol. 249, no. 4968, 1990, pages 505 - 510
METHODS ENZYMOL., vol. 267, 1996, pages 275 - 301
METHODS ENZYMOL., vol. 318, 2000, pages 193 - 214
NUCL. ACID RES., vol. 14, 1986, pages 5399 - 5467
TET. LETT., vol. 27, 1986, pages 5575 - 5578
NUCL. ACID RES., vol. 4, 1977, pages 2557
LETT., vol. 28, 1978, pages 2449
SCIENCE, vol. 263, no. 5152, 1994, pages 1425 - 1429
MOL THER, vol. 4, no. 6, 2001, pages 567 - 573
CHEM BIOL, vol. 9, no. 3, 2002, pages 351 - 359
COTTEN ET AL., NUCL. ACID RES., vol. 19, 1991, pages 2629 - 2635
HOBBS ET AL., BIOCHEMISTRY, vol. 12, 1973, pages 5138 - 5145
SCIENCE, vol. 286, 1999, pages 2305 - 2308
NUCLEIC ACIDS RES., vol. 30, no. 24, 2002, pages 138
NUCLEIC ACID THER., vol. 21, no. 3, June 2011 (2011-06-01), pages 173 - 178
PROC. NATL. ACAD. SCI. USA., vol. 109, no. 33, 2012, pages 13237 - 42
CRIT. REV. ONCOL. HEMATOL., vol. 66, no. 2, 2008, pages 91 - 98
See also references of EP 3530738A4
ANNU. REV. MED., vol. 45, 1994, pages 491 - 503
INT IMMUNOPHARMACOL., vol. 8, no. 5, 2008, pages 679 - 87
BIOCONJUG. CHEM., vol. 24, no. 6, 2013, pages 915 - 25
GENE THER., vol. 14, no. 4, 2007, pages 283 - 291
SCIENCE, vol. 249, no. 4968, 1990, pages 505 - 510
METHODS ENZYMOL., vol. 267, 1996, pages 275 - 301
METHODS ENZYMOL., vol. 318, 2000, pages 193 - 214
NUCL. ACID RES., vol. 14, 1986, pages 5399 - 5467
TET. LETT., vol. 27, 1986, pages 5575 - 5578
NUCL. ACID RES., vol. 4, 1977, pages 2557
LETT., vol. 28, 1978, pages 2449
SCIENCE, vol. 263, no. 5152, 1994, pages 1425 - 1429
MOL THER, vol. 4, no. 6, 2001, pages 567 - 573
CHEM BIOL, vol. 9, no. 3, 2002, pages 351 - 359
COTTEN ET AL., NUCL. ACID RES., vol. 19, 1991, pages 2629 - 2635
HOBBS ET AL., BIOCHEMISTRY, vol. 12, 1973, pages 5138 - 5145
SCIENCE, vol. 286, 1999, pages 2305 - 2308
NUCLEIC ACIDS RES., vol. 30, no. 24, 2002, pages 138
NUCLEIC ACID THER., vol. 21, no. 3, June 2011 (2011-06-01), pages 173 - 178
PROC. NATL. ACAD. SCI. USA., vol. 109, no. 33, 2012, pages 13237 - 42
CRIT. REV. ONCOL. HEMATOL., vol. 66, no. 2, 2008, pages 91 - 98
See also references of EP 3530738A4
Attorney, Agent or Firm:
TW INTERNATIONAL PATENT AND LAWFIRM (KR)
Download PDF: